Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-072705
Filing Date
2023-03-16
Accepted
2023-03-16 16:57:37
Documents
5
Effectiveness Date
2023-03-16

Document Format Files

Seq Description Document Type Size
1 S-8 d480523ds8.htm S-8 56835
2 EX-5.1 d480523dex51.htm EX-5.1 6622
3 EX-23.1 d480523dex231.htm EX-23.1 1174
4 EX-FILING FEES d480523dexfilingfees.htm EX-FILING FEES 21918
5 GRAPHIC g480523page2a.jpg GRAPHIC 4834
  Complete submission text file 0001193125-23-072705.txt   94386
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270619 | Film No.: 23739590
SIC: 2834 Pharmaceutical Preparations